Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency
- PMID: 16701788
- DOI: 10.1016/j.virol.2006.03.047
Intracellular-activated Notch1 can reactivate Kaposi's sarcoma-associated herpesvirus from latency
Abstract
Kaposi's sarcoma-associated herpesvirus (KSHV) establishes a predominantly latent infection in the infected host. Importantly, during latency, only a small number of viral encoded genes are expressed. This viral gene expression pattern contributes to the establishment of long-term infection as well as the ability of the virus to evade the immune system. Previous studies have been shown that the replication and transcription activator (RTA) encoded by ORF50 activates it downstream genes and initiates viral lytic reactivation through functional interaction with RBP-Jkappa, the major downstream effector of the Notch signaling pathway. This indicates that RTA can usurp the conserved Notch signaling pathway and mimic the activities of intracellular Notch1 to modulate gene expression. In this report, we show that the activated intracellular domain of Notch1 (ICN) is aberrantly accumulated in KSHV latently infected pleural effusion lymphoma (PEL) cells. ICN activated the RTA promoter in a dose-dependent manner, and forced expression of ICN in latently infected KSHV-positive cells initiated full blown lytic replication with the production of infectious viral progeny. However, latency-associated nuclear antigen (LANA) which is predominantly expressed during latency can specifically down-modulate ICN-mediated transactivation of RTA and so control KSHV for lytic reactivation. These results demonstrate that LANA can inhibit viral lytic replication by antagonizing ICN function and suggest that LANA is a critical component of the regulatory control mechanism for switching between viral latent and lytic replication by directly interacting with effectors of the conserved cellular Notch1 pathway.
Similar articles
-
Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.Proc Natl Acad Sci U S A. 2003 Jul 8;100(14):8490-5. doi: 10.1073/pnas.1432843100. Epub 2003 Jun 27. Proc Natl Acad Sci U S A. 2003. PMID: 12832621 Free PMC article.
-
The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway.Genes Dev. 2002 Aug 1;16(15):1977-89. doi: 10.1101/gad.996502. Genes Dev. 2002. PMID: 12154127 Free PMC article.
-
Notch signal transduction induces a novel profile of Kaposi's sarcoma-associated herpesvirus gene expression.J Microbiol. 2006 Apr;44(2):217-25. J Microbiol. 2006. PMID: 16728959
-
Lytic cycle switches of oncogenic human gammaherpesviruses.Adv Cancer Res. 2007;97:81-109. doi: 10.1016/S0065-230X(06)97004-3. Adv Cancer Res. 2007. PMID: 17419942 Review.
-
The role of Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 regulator of transcription activation (RTA) in control of gene expression.Oncogene. 2003 Aug 11;22(33):5150-63. doi: 10.1038/sj.onc.1206555. Oncogene. 2003. PMID: 12910252 Review.
Cited by
-
Gamma-herpesviruses and cellular signaling in AIDS-associated malignancies.Cancer Sci. 2007 Sep;98(9):1288-96. doi: 10.1111/j.1349-7006.2007.00555.x. Epub 2007 Jul 19. Cancer Sci. 2007. PMID: 17640300 Free PMC article. Review.
-
Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities.Virology. 2009 Jun 5;388(2):236-47. doi: 10.1016/j.virol.2009.03.027. Epub 2009 Apr 24. Virology. 2009. PMID: 19394062 Free PMC article.
-
The Impact of Co-Infections for Human Gammaherpesvirus Infection and Associated Pathologies.Int J Mol Sci. 2023 Aug 22;24(17):13066. doi: 10.3390/ijms241713066. Int J Mol Sci. 2023. PMID: 37685871 Free PMC article. Review.
-
Detection of Epstein-Barr virus in T-cell prolymphocytic leukemia cells in vitro.J Clin Virol. 2008 Nov;43(3):260-5. doi: 10.1016/j.jcv.2008.07.018. Epub 2008 Sep 14. J Clin Virol. 2008. PMID: 18790666 Free PMC article.
-
KSHV reactivation from latency requires Pim-1 and Pim-3 kinases to inactivate the latency-associated nuclear antigen LANA.PLoS Pathog. 2009 Mar;5(3):e1000324. doi: 10.1371/journal.ppat.1000324. Epub 2009 Mar 6. PLoS Pathog. 2009. PMID: 19266083 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources